Managing drug-resistant tuberculosis: from new guidelines to clinical practice

Guidelines session
Chairs: R. Duarte (Porto, Portugal), S. Tiberi (London, United Kingdom)
Aims: to present the new guidelines for multidrug-resistant (MDR)-TB; to discuss similarities and differences with the newly published World Health Organization guidelines; to discuss the best management of challenging clinical cases affected by MDR- or extensively drug-resistant-TB, including paediatric cases.

The new ATS/ERS/IDSA/CDC guidelines for MDR-TB: rationale, methods and recommendations G. Migliori (Varese (VA), Italy)
Similarities and differences among existing guidelines G. Sotgiu (Porto Torres (SS), Italy)
Research and clinical trial needs and the challenges associated with recommending pan-oral regimens: the Latin-American and African perspective G. Perez Mendoza (Las Palmas, Spain)
Managing difficult cases from the Russian Federation and beyond: an interactive session S. Borisov (Moscow, Russian Federation)